Karyopharm Therapeutics
-$0.30 (-5.37%) Today
+$0.03 (+0.57%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.
About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).
CEO
Richard A. Paulson
Employees
432
Headquarters
Newton, Massachusetts
Founded
2008
KPTI Key Statistics
Market Cap
399.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.06M
High Today
$5.58
Low Today
$5.23
Open Price
$5.58
Volume
1.47M
52 Week High
$18.00
52 Week Low
$4.42
Analyst Ratings
60%
of 10 ratings
Buy
60%
Hold
30%
Sell
10%
KPTI Earnings
-$0.78
-$0.52
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 1, After Hours